| Size | Price | Stock | Qty |
|---|---|---|---|
| 5g |
|
||
| 10g |
|
||
| 25g |
|
||
| Other Sizes |
| Targets |
Sephadex G 50 does not have a biological target. It is a chromatography resin used for the purification and fractionation of biomolecules. The resin separates molecules based on size, with the separation range determined by the degree of cross-linking. Sephadex G 50 has an exclusion limit of approximately 30,000 Da for globular proteins, making it suitable for separating small molecules from larger proteins.
|
|---|---|
| ln Vitro |
Sephadex G 50 is not used in cell-based assays. Its applications are in biochemical purification and separation. The resin is used to desalt protein samples, exchange buffers, and fractionate glycopeptide mixtures. It is not tested for biological activity in vitro.
|
| ln Vivo |
Sephadex G 50 is not administered to animals. It is used in laboratory settings for the purification of biomolecules from biological samples. The resin itself is not a therapeutic agent and has no in vivo applications.
|
| Enzyme Assay |
Sephadex G 50 is not used in enzyme/receptor binding assays. It is a chromatography resin used for size-based separation of biomolecules. The resin is packed into columns, and samples are applied and eluted with buffer. The separation is based on molecular size, with smaller molecules being retarded and larger molecules eluting first.
|
| Cell Assay |
Sephadex G 50 is not used in cell-based assays. Its applications are in biochemical purification and separation of biomolecules from cell lysates or other biological samples. The resin is used to remove small molecules (e.g., salts, nucleotides) from protein samples or to fractionate complex mixtures.
|
| Animal Protocol |
Sephadex G 50 is not used in animal studies. It is a laboratory reagent for protein purification and is not administered to animals.
|
| ADME/Pharmacokinetics |
Sephadex G 50 is a chromatography resin and is not subject to pharmacokinetic evaluation. Its physicochemical properties include a particle size of 50–150 µm and pH stability from 2 to 13. The resin is stable when stored at -20°C. It is a cross-linked dextran bead that swells in aqueous buffers. The exclusion limit for globular proteins is approximately 30,000 Da.
|
| Toxicity/Toxicokinetics |
Sephadex G 50 is considered non-toxic as a chromatography resin. Standard laboratory safety precautions should be observed when handling the dry powder, as it may cause respiratory irritation. The resin is not classified as hazardous.
|
| References |
|
| Additional Infomation |
Sephadex G 50 is not a drug but a well-established gel filtration medium used in biochemistry and molecular biology. It is used for desalting, buffer exchange, and fractionation of biomolecules. Applications include affinity chromatography, protein chromatography, and gel filtration chromatography. It is also used for the fractionation of glycopeptide mixtures. It is not approved for clinical use.
|
| Molecular Formula |
C11H9N3O2.NA+
|
|---|---|
| Molecular Weight |
238.19786
|
| Exact Mass |
500.177
|
| CAS # |
9048-71-9
|
| Related CAS # |
Sephadex G 200;9041-36-5;Sephadex G 15;11081-40-6;Sephadex G 10;9050-68-4;Sephadex G 150;12774-36-6
|
| PubChem CID |
135350673
|
| Appearance |
White to off-white solid powder
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
8
|
| Heavy Atom Count |
36
|
| Complexity |
779
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[Na+].O=C1C=C/C(=N/NC2=CC=CC=N2)/C(O)=C1
|
| InChi Key |
HPAPUVLGQATAGV-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C29H28N2O4S/c1-29(2,3)17-12-13-23-25(14-17)36-26(30-23)15-24(27(32)33)31-28(34)35-16-22-20-10-6-4-8-18(20)19-9-5-7-11-21(19)22/h4-14,22,24H,15-16H2,1-3H3,(H,31,34)(H,32,33)
|
| Chemical Name |
3-(6-tert-butyl-1,3-benzothiazol-2-yl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solubility (In Vivo) |
Dextran Gel G Series Instructions for Use 1. Chemical and Physical Properties Dextran Gel is a beaded gel containing a large number of hydroxyl groups, allowing it to swell readily in water and electrolyte solutions. The hydrophilic matrix minimizes non-specific adsorption and provides high recovery rates during biomolecule separation. G-type Dextran Gels have varying degrees of cross-linking, resulting in different swelling degrees and fractionation ranges. The swelling degree of Dextran Gel is essentially unaffected by the presence of salts or detergents. 2. Product Specifications
3. Usage Instructions Sephadex series products are supplied as dry powders and must be swollen before use. Avoid excessive stirring during swelling as it may damage the packing material. Do not use magnetic stirrers. 3.1 Packing Material Preparation (1) Swell the packing material in an excess of deionized water or buffer at room temperature for 24 hours, or in hot water for 1 hour (Not in a water bath!). The elution buffer should not contain high-viscosity reagents. If floating matter appears on the upper layer during swelling, remove it. (2) Equilibrate the swollen packing material and all buffers to the experimental operating temperature. Degas all buffers. 3.2 Column Packing (1) Inspect all column components, especially the filter screen, sealing ring, and screw plug for tightness. Ensure the glass tube is clean and intact. (2) Wet the column interior and bottom end with water or buffer, maintaining a small liquid level. Ensure no air bubbles are present at the bottom. (3) Use a glass rod to guide the slurry into the column along the inner wall in one continuous pour, avoiding bubble formation. Open the column outlet to allow the gel to settle freely within the column. Connect the top column end fitting securely. (4) Start the peristaltic pump and allow buffer to flow through the column at 1.33 times the operating flow rate to stabilize the bed (Ensure pressure does not exceed the maximum pressure resistance of the packing material). 3.3 Equilibration Equilibrate the column with at least 5-10 column volumes (CV) of buffer before sample application until the recorder baseline stabilizes (i.e., the pH and conductivity of the effluent equal those of the application buffer). 3.4 Sample Application Samples must be centrifuged or filtered (0.45 µm filter) before application. For gel filtration, the sample volume is generally no more than 5% of the bed volume. For initial runs, it is recommended to load 1-2% of the bed volume and adjust based on separation results. For desalting, sample volumes up to 20% of the bed volume can be applied. Column height also affects separation; taller columns provide better resolution but cause higher backpressure and should be avoided if possible. Challenging separations require adequate column height and flow rate control. For desalting, a height-to-diameter ratio of 5:1 is sufficient. 3.5 Elution Method Elution can be performed using salt-free water or the buffer used during column packing. 3.8 Cleaning In Place (CIP) Perform CIP after every ten uses to remove precipitated and stubbornly adsorbed proteins. Method: Wash with 0.1 M NaOH for 2 column volumes (CV), followed by regeneration with at least 10 CV of equilibration buffer. 4. Storage Untreated Packing Material: Store sealed at room temperature. Used Packing Material: Thoroughly rinse out salts with pure water. Finally, store in 20% ethanol at 4°C. 5. Precautions a) Before sample application, samples must be membrane-filtered and decolorized. Otherwise, impurities and pigments may adsorb onto the packing material, affecting its performance. All buffers must be filtered through a 0.45 µm filter. 6. Particle Size Specifications Fine Particles: Slow flow rate, optimal separation resolution. Coarse Particles: Fast flow rate, reduced separation resolution. Medium Particles: Moderate flow rate, moderate separation resolution. This type is most commonly selected by customers.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.1982 mL | 20.9908 mL | 41.9815 mL | |
| 5 mM | 0.8396 mL | 4.1982 mL | 8.3963 mL | |
| 10 mM | 0.4198 mL | 2.0991 mL | 4.1982 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.